Computer simulation of dementia care demand heterogeneity using hybrid simulation methods: improving population-level modelling with individual patient decline trajectories.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 06 02 2020
revised: 24 06 2020
accepted: 14 07 2020
pubmed: 31 8 2020
medline: 9 2 2021
entrez: 31 8 2020
Statut: ppublish

Résumé

The aim of the study was to model dementia prevalence and outcomes within an ageing population using a novel hybrid simulation model that simultaneously takes population-level and patient-level perspectives to better inform dementia care service planning, taking into account severity progression variability. This is a simulation study. We developed a hybrid computer simulation combining different methods to best represent population and individual dementia dynamics. Individual patient outcomes are aggregated into three progression rate types to report the effects of severity progression variability and intervention benefits. Fast progression of dementia severity is associated with higher annual care cost and short overall survival duration. Those patients are more likely to develop moderate to severe symptoms more quickly, highlighting a need for more urgent provision of appropriate care services. Slower severity progression is associated with lower annual care costs, but longer survival requires higher overall financial provision. Although lifestyle interventions reduce overall care costs, treatment and lifestyle intervention benefits are modest at the population level. Individual variation of dementia decline is an important factor to include in planning adequate levels of care services and to ensure timely and appropriate service availability. Hybrid simulation models provide useful insights at the population and individual level, supporting effective decision-making.

Identifiants

pubmed: 32861920
pii: S0033-3506(20)30313-9
doi: 10.1016/j.puhe.2020.07.018
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

197-203

Informations de copyright

Copyright © 2020 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Auteurs

D Evenden (D)

Southampton Business School, University of Southampton, Southampton, UK; School of Health Sciences, University of Southampton, Southampton, UK. Electronic address: dave.evenden@soton.ac.uk.

S Brailsford (S)

Southampton Business School, University of Southampton, Southampton, UK.

C Kipps (C)

University Hospital Southampton, Southampton, UK.

P Roderick (P)

School of Medicine, University of Southampton, Southampton, UK.

B Walsh (B)

School of Health Sciences, University of Southampton, Southampton, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH